Clinical Trials Directory

Trials / Completed

CompletedNCT01662609

Protocol for High-Risk Assessment, Screening, and Early Detection of Pancreatic Cancer

Protocol for High-Risk Assessment, Screening, and Early Detection of Pancreatic Cancer at Moffitt Cancer Center and Lehigh Valley Hospital

Status
Completed
Phase
Study type
Observational
Enrollment
90 (actual)
Sponsor
H. Lee Moffitt Cancer Center and Research Institute · Academic / Other
Sex
All
Age
30 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to find out whether Endoscopic Ultrasound (EUS) can detect early stage pre-cancerous or cancerous changes in the pancreas in patients at high-risk for the development of pancreatic cancer. Endoscopic refers to the use of an instrument called an endoscope - a thin, flexible tube with a tiny video camera and light on the end. Ultrasound refers to an imaging technique that uses sound waves to produce pictures. EUS in this research study is a method of combining endoscopy and ultrasound imaging to obtain high quality images of the pancreas.

Conditions

Interventions

TypeNameDescription
PROCEDUREEndoscopic Ultrasound (EUS)Ultrasound scope will be passed through the participant's mouth into their stomach and their pancreas will be evaluated completely by the ultrasound scope. If an abnormality is found in their pancreas, a biopsy may be performed to obtain a diagnosis.

Timeline

Start date
2007-08-23
Primary completion
2022-08-16
Completion
2022-08-16
First posted
2012-08-10
Last updated
2022-10-07

Locations

2 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT01662609. Inclusion in this directory is not an endorsement.